Dr. Michael Hamblin, PhD

Scientific Advisor to Joovv

Dr. Michael R. Hamblin is a leading researcher in photomedicine and photobiomodulation (PBM), also known as red light therapy. His work has helped shape scientific understanding of how light-based therapies may interact with biological tissues and cellular processes.

As Scientific Advisor to Joovv, Dr. Hamblin provides guidance on emerging photobiomodulation research, clinical findings, educational content, and the evolving science behind red and near-infrared light therapy.

Academic & Research Background

Prof. M.R. Hamblin, PhD, was the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School, and a member of the affiliated faculty of the Harvard-MIT Division of Health Sciences and Technology.

His academic work, which contains over 422 peer-reviewed articles, spans photomedicine, photobiomodulation, low-level light therapy, dermatology, and clinical research.

Role at Joovv

As Scientific Advisor, Dr. Hamblin supports Joovv through:

• Scientific review of emerging photobiomodulation research
• Interpretation of clinical findings and study outcomes
• Educational content development
• Scientific accuracy review
• Guidance on future research initiatives

His expertise helps Joovv stay connected to the broader scientific literature surrounding red and near-infrared light therapy.

Advancing Photobiomodulation Education

Photobiomodulation is an evolving field with growing research interest across health, recovery, performance, and clinical science. Through his advisory role, Dr. Hamblin helps Joovv communicate the science of light therapy with accuracy, clarity, and scientific integrity.

His guidance supports Joovv’s commitment to evidence-based education and responsible communication around red and near-infrared light therapy.